I want to give a couple of plugs for interesting new health news blogs.
The Wall Street Journal health news blog is terrific.
One recent entry was on the trial that âshowed that using stents in stable patients with mild to moderate chest pain doesnât reduce the risk of heart attacks compared with drugs alone. ⦠The Health Blogâs take-away: The idea of clearing out clogged arteries is so appealing, and the idea of leaving them clogged so terrifying, that patients and doctors are inclined to open them up, even if the data say that wonât do much good.â?
And another entry analyzed the new questions about the benefits of mammography for women in their 40s. It included a quote from a mammography expert: âThe evidence shows that it does help some women [in their 40s] â” but the evidence shows that itâs only six out of 10,000 over a decade.â? If only some mainstream news media could analyze the data as concisely as that.
Another noteworthy blog is Pharmalot.com – âa home for lively discussion about news and trends in the pharmaceutical industry. The guy behind the curtain is Ed Silverman, a veteran journalist for The Star-Ledger of New Jersey.â? Interestingly, this is Edâs fulltime baby. He doesnât even file for the paper anymore.
It’s good to see that some news organizations are catching on to this Web thing.
Opinions on other issues in news, journals, PR, advertising, marketing
Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's @CarlaKJohnson. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d
Come on, NY Times; you must do better than this. Important research doesn’t need hype and the “breaking news” BS doesn’t help readers or patients. https://www.healthnewsreview.org/2022/03/nyt-proclaims-breaking-news/
Comments
Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.
Comments are closed.
Our Comments Policy
But before leaving a comment, please review these notes about our policy.
You are responsible for any comments you leave on this site.
This site is primarily a forum for discussion about the quality (or lack thereof) in journalism or other media messages (advertising, marketing, public relations, medical journals, etc.) It is not intended to be a forum for definitive discussions about medicine or science.
We will delete comments that include personal attacks, unfounded allegations, unverified claims, product pitches, profanity or any from anyone who does not list a full name and a functioning email address. We will also end any thread of repetitive comments. We don”t give medical advice so we won”t respond to questions asking for it.
We don”t have sufficient staffing to contact each commenter who left such a message. If you have a question about why your comment was edited or removed, you can email us at feedback@healthnewsreview.org.
There has been a recent burst of attention to troubles with many comments left on science and science news/communication websites. Read “Online science comments: trolls, trash and treasure.”
The authors of the Retraction Watch comments policy urge commenters:
We”re also concerned about anonymous comments. We ask that all commenters leave their full name and provide an actual email address in case we feel we need to contact them. We may delete any comment left by someone who does not leave their name and a legitimate email address.
And, as noted, product pitches of any sort – pushing treatments, tests, products, procedures, physicians, medical centers, books, websites – are likely to be deleted. We don”t accept advertising on this site and are not going to give it away free.
The ability to leave comments expires after a certain period of time. So you may find that you’re unable to leave a comment on an article that is more than a few months old.
You might also like